|
NCOA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.48103751484996E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64834812466097E-12 |
| Normal-vs-Stage2 |
7.86489999793361E-08 |
| Normal-vs-Stage3 |
2.14429995981646E-09 |
| Normal-vs-Stage4 |
1.90579996228735E-09 |
| Stage1-vs-Stage2 |
4.224800E-01 |
| Stage1-vs-Stage3 |
8.079400E-01 |
| Stage1-vs-Stage4 |
1.721640E-01 |
| Stage2-vs-Stage3 |
6.065600E-01 |
| Stage2-vs-Stage4 |
6.011600E-02 |
| Stage3-vs-Stage4 |
1.469760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62481139653892E-12 |
| Normal-vs-AfricanAmerican |
5.1073000273405E-09 |
| Normal-vs-Asian |
3.604800E-04 |
| Caucasian-vs-AfricanAmerican |
7.275400E-03 |
| Caucasian-vs-Asian |
5.198600E-01 |
| AfricanAmerican-vs-Asian |
7.701800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.83549999982691E-07 |
| Male-vs-Female |
2.396800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.23117138285079E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
7.02310432032505E-11 |
| Normal-vs-Extreme_Obese |
3.79320000000183E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.649800E-01 |
| Normal_Weight-vs-Obese |
2.658200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.412400E-01 |
| Extreme_Weight-vs-Obese |
4.533700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.816780E-01 |
| Obese-vs-Extreme_Obese |
9.039800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.13350000000312E-05 |
| Normal-vs-Age(41-60Yrs) |
5.82112136271462E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
1.86290000092626E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.417000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.561200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.187600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.876900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.205000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.902200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6278089987054E-12 |
| Normal-VS-Type2 PRCC |
2.33146835171283E-15 |
| Normal-VS-KIRP CIMP |
1.76856999999364E-05 |
| Normal-VS-Unclassified PRCC |
1.95343999999098E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.471500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.051600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.478240E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.645020E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.428500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.522800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.88178419700125E-16 |
| Normal-vs-N1 |
6.80739999925351E-08 |
| Normal-vs-N2 |
4.33859999999786E-05 |
| N0-vs-N1 |
6.620300E-02 |
| N0-vs-N2 |
9.210400E-01 |
| N1-vs-N2 |
3.743000E-01 |
|
|
